中文
| Catalogue |
|
|
| Recommend Products |
ENPICOM B.V.
Netherlands, Service, Hits: 973, Updated:11/9/2020
Startup Village Unit A.07, Science Park 608 1098 XH, Amsterdam |
Company Profile
-
ENPICOM is an innovative bioinformatics software engineering company delivering ground-breaking products and customized solutions to decode the immune system and improve human health. With a diverse team of over 25 professionals, ENPICOM serves customers from all over the world, from academic research centers doing basic research related to the immune system to biotech and global pharmaceutical companies focusing on the discovery and development of novel immunotherapies and vaccines. Clinical validation projects to stratify patients and monitor treatment responses to immunotherapies under development are ongoing.
Leveraging a unique mix of biological knowledge, bioinformatics method development, and software engineering skills, ENPICOM developed a world-class repertoire sequencing data analysis solution, the ImmunoGenomiX (IGX) platform. IGX is an innovative platform to manage, store, analyze, visualize, and interpret immune repertoire sequencing data from T and B cell receptors. The smart analysis and visualization methods are also offered as IGX-service. In collaboration with DDL Diagnostic Laboratory, ENPICOM delivers full immune repertoire sequencing and analysis service.
Company News
- ENPICOM Partners with Erasmus University Medical Center in Groundbreaking Effort to Discover Nanob... 2/21/2024
- ENPICOM Launches Versatile Display Data Analysis Solution 5/30/2022
- ENPICOM Secures Series B Funding to Scale up Operations to Meet the High Demand for its Antibody D... 1/14/2022
- ENPICOM Participates in Inno4vac, a European New Public-private Partnership to Innovate Vaccine De... 10/12/2021
- ENPICOM Introduces a Powerful Liability Prediction Solution to De-risk Antibody Development 9/14/2021
- ENPICOM to Integrate Renowned Structural Antibody Prediction Tools Developed at the University of ... 6/11/2021
- Zai Lab Selects ENPICOM’s IGX Platform to Leverage New NGS-powered Antibody Discovery Workflows 6/3/2021
- ENPICOM and Viroclinics-DDL Receive Joint MIT Zuid Subsidy to Accelerate and Improve Antibody and ... 3/31/2021
- ENPICOM Introduces an End-to-end Solution for Fast and Efficient Antibody Discovery 1/28/2021
- ENPICOM and MiLaboratories Join Forces to Power Better Repertoire Sequencing Data Management and A... 12/16/2020